Sydney Head and Neck Cancer Institute, Royal Prince Alfred Hospital, Camperdown, Australia.
Cancer. 2011 Oct 1;117(19):4460-7. doi: 10.1002/cncr.26032. Epub 2011 Mar 22.
A study was undertaken to determine whether bone invasion is an independent prognostic factor in oral squamous cell carcinoma (SCC) after taking into account the extent of bone invasion.
The study was a retrospective review of 498 patients with oral SCC undergoing surgery with curative intent, 102 of whom had pathologically proven bone invasion. Bone invasion was categorized as absent, cortical, or medullary and tested for association with disease control and survival.
After adjusting for potential confounding factors in multivariate analysis, there was no association between cortical invasion and overall (P = .48) or disease-specific survival (P = .63). In contrast, medullary invasion was an independent predictor of reduced overall (hazard ratio [HR], 1.9; 95% confidence interval [CI], 1.2-3.1; P = .006) and disease-specific survival (HR, 2.1; 95% CI, 1.2-3.6; P = .01), and this appeared to result from an increased risk of distant metastatic failure (P = .037) rather than local (P = .51) or regional recurrence (P = .14). Within the subset of patients with medullary invasion, survival differed significantly according to tumor size (P = .029).
Patients with oral SCC and bone invasion have widely variable outcomes depending on the depth of bone invasion and tumor size. The results suggest that the current American Joint Committee on Cancer staging system, which classifies all tumors invading through cortical bone as T4, has limited prognostic utility. The authors recommend a revision of the T staging system such that tumors are classified as T1 to T3 based on size and then upstaged by 1 T stage in the presence of medullary bone invasion.
本研究旨在探讨在考虑骨侵犯程度的情况下,骨侵犯是否为口腔鳞状细胞癌(SCC)的独立预后因素。
该研究回顾性分析了 498 例接受根治性手术的口腔 SCC 患者,其中 102 例病理证实有骨侵犯。骨侵犯分为无、皮质和骨髓,并检测其与疾病控制和生存的相关性。
在多变量分析中调整了潜在混杂因素后,皮质侵犯与总生存(P =.48)或疾病特异性生存(P =.63)均无相关性。相比之下,骨髓侵犯是总生存(危险比 [HR],1.9;95%置信区间 [CI],1.2-3.1;P =.006)和疾病特异性生存(HR,2.1;95% CI,1.2-3.6;P =.01)的独立预测因子,这似乎是由于远处转移失败风险增加(P =.037),而不是局部(P =.51)或区域复发(P =.14)。在骨髓侵犯患者亚组中,根据肿瘤大小,生存情况差异有统计学意义(P =.029)。
口腔 SCC 伴骨侵犯患者的预后差异很大,取决于骨侵犯的深度和肿瘤大小。结果表明,目前美国癌症联合委员会(AJCC)分期系统将所有侵犯皮质骨的肿瘤均归类为 T4,其预后预测能力有限。作者建议修订 T 分期系统,根据肿瘤大小将其分为 T1 至 T3 期,然后在存在骨髓骨侵犯的情况下再升 1 期。